Keywords: ares-serono, lifts, market, share, switzerland-based, drugs, diagnostics
ARES-SERONO LIFTS MARKET SHARE
Article | 29 November 1993
Switzerland-based drugs and diagnostics firm Ares-Serono says world-wide sales for the first nine months of 1993, in local currency terms, were $548.3 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
